Nucleix
PrivateLast Round
Series C
Extension
Dec 30, 2021
Total Funding Raised
$91.45M
Company Overview
Nucleix is a biotechnology company that develops non-invasive molecular diagnostic tests to enhance the accuracy and effectiveness of cancer detection through the use of DNA methylation patterns and proprietary biomarker assays.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleix Comps
Public and private peers based on sector, stage, and business model.
Nucleix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Dec 30, 2021 | ||||
| Series C | Apr 7, 2021 | ||||
| Grant | Jul 30, 2018 | ||||
| Series B | May 23, 2016 | ||||
| Grant | Mar 1, 2016 | ||||
Series A | Jun 16, 2014 |
Key People
Founding team and executive leadership
Nucleix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aurum Ventures | Series C |
| DSC Investment | Series C |
| RA Capital Management | Series C Extension, Series C |
| European Commission (Horizon Europe) | Grant |
| LYFE Capital | Series C |
| OrbiMed | Series C Extension, Series C, Series A |
| Aurum Ventures MKI | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2025
Presenting Bladder EpiCheck data at the AUA 2025 conference.
Nucleix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nucleix's valuation, stock price, and market status.
